Doctor Care (ASX:DOC) share price slides 11% after quarterly results

The telehealth provider has had an off-colour morning on the ASX.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Doctor Care Anywhere Group Plc (ASX: DOC) share price has slipped into the red in early trading on Wednesday. Today's dip comes as the company released its quarterly results this morning.

Let's examine Doctor Care's results in a bit finer detail.

a doctor with stethoscope around neck sits as a computer with head in hand, looking despondent.

Image source: Getty Images

But first – a bit more on Doctor Care

Doctor Care has expertise in providing digital healthcare and telehealth services to patients.

It has a network of insurers, healthcare providers and corporate customers designed to connect with patients.

The company has a market capitalisation of $279 million at the time of writing.

Doctor Care's quarterly results

The company recorded unaudited revenue of $8.9 million this quarter, a 78% year-on-year increase.

It also delivered 89,400 consultations across the quarter, a healthy expansion of 69% from the year prior.

Doctor Care's "recruitment drive" also added 71 new GPs to its platform, with a further 100 in the pipeline.

As a result of these additions, the company hopes to provide "up to 45,000 appointment capacity" per month by the end of Q3.

Diagnostic referral volumes were also up 34% from the previous quarter and broad strengths were underlined by "continued demand as the UK economy unlocks".

While people entitled to use the company's services remained flat from the previous quarter at 2.4 million, its "activated lives" — or people signing up for the service — grew 12.7% quarter-on-quarter and 90% from the year prior.

Additional takeouts

With respect to guidance, Doctor Care reinstated its FY21 estimates of "revenue growth of at least 100% above FY 2020".

For reference, Doctor Care recognised revenue of $11.6 million for the FY 2020 and made a loss of $31.3 million.

Commenting on the performance this quarter, Doctor Care CEO Dr Bayju Thakar stated:

Our outlook for 2021 remains positive following a robust performance in a quarter during which patient demand has continued to grow rapidly… Nevertheless, this has been a quarter of significant challenges as a result of the demand on GPs to deliver the national vaccination programme.

The company's chair Jonathan Baines added:

The UK primary health care system will continue to remain under extreme pressure, contributing to significantly increased demand for our service as demonstrated by the growth in activated lives and record number of daily consultations this quarter. We remain confident in our guidance for year on year revenue growth of at least 100% above FY 2020.

However, investors seem to view the results unfavourably and are selling Doctor Care shares in droves this morning.

After earlier trading down ~11% on their opening price, Doctor Care shares are now changing hands for 80 cents, an 8.5% drop at the time of writing.

Doctor Care share price snapshot

The Doctor Care share price has posted a year to date loss of almost 34%, extending the previous 12 months' loss of close to 15%.

These returns have lagged the S&P/ASX 200 Index (ASX: XJO)'s return of ~23% over the previous year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three brightly coloured objects against a backdrop of blue, indication three winning ASX share prices
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre session on the ASX this Thursday.

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »